Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
AMRN Amarin Corp Plc
- Stocks
- Healthcare
- NASDAQ: AMRN
Price (delayed)
$17.32
Market cap
$358.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.4
Enterprise value
$246.8M
Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its
Highlights
AMRN's quick ratio is up by 26% year-on-year and by 3% since the previous quarter
AMRN's debt is down by 5% year-on-year but it is up by 2.8% since the previous quarter
The company's EPS has shrunk by 69% YoY and by 10% QoQ
AMRN's net income has plunged by 67% YoY and by 7% from the previous quarter
Key stats
What are the main financial stats of AMRN
Market
Valuations
Earnings
Shares outstanding
20.71M
Market cap
$358.69M
Enterprise value
$246.8M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.76
Price to sales (P/S)
1.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.15
Revenue
$214.11M
Gross profit
$74.61M
Operating income
-$94.97M
Net income
-$87.93M
EBIT
-$81.66M
EBITDA
-$78.68M
Free cash flow
-$30.88M
Per share
Balance sheet
Liquidity
EPS
-$4.4
EPS diluted
-$4.4
Free cash flow per share
-$1.49
Book value per share
$22.87
Revenue per share
$10.36
TBVPS
$30.96
Total assets
$655.68M
Total liabilities
$181.99M
Debt
$7.94M
Equity
$473.69M
Working capital
$410.65M
Debt to equity
0.02
Current ratio
3.53
Quick ratio
2.39
Net debt/EBITDA
1.42
Margins
Efficiency
Dividend
EBITDA margin
-36.7%
Gross margin
34.8%
Net margin
-41.1%
Operating margin
-44.4%
Return on assets
-12.2%
Return on equity
-17.2%
Return on invested capital
-22.3%
Return on capital employed
-16.6%
Return on sales
-38.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AMRN stock price
How has the Amarin stock price performed over time
Intraday
-0.06%
1 week
3.53%
1 month
35.1%
1 year
14.17%
YTD
78.56%
QTD
6.78%
Financial performance
How have Amarin's revenue and profit performed over time
Revenue
$214.11M
Gross profit
$74.61M
Operating income
-$94.97M
Net income
-$87.93M
Gross margin
34.8%
Net margin
-41.1%
AMRN's net margin has dropped by 116% year-on-year and by 14% since the previous quarter
AMRN's operating margin has dropped by 93% year-on-year and by 10% since the previous quarter
AMRN's net income has plunged by 67% YoY and by 7% from the previous quarter
Amarin's gross profit has shrunk by 50% YoY and by 8% QoQ
Price vs fundamentals
How does AMRN's price correlate with its fundamentals
Growth
What is Amarin's growth rate over time
Valuation
What is Amarin stock price valuation
P/E
N/A
P/B
0.76
P/S
1.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.15
The company's EPS has shrunk by 69% YoY and by 10% QoQ
AMRN's P/B is 52% above its last 4 quarters average of 0.5 but 49% below its 5-year quarterly average of 1.5
The equity has declined by 13% year-on-year and by 2.6% since the previous quarter
The P/S is 67% more than the last 4 quarters average of 1.0 but 7% less than the 5-year quarterly average of 1.8
The revenue is down by 23% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is Amarin business performance
The company's return on sales has shrunk by 115% YoY and by 13% QoQ
Amarin's ROA has plunged by 94% YoY and by 12% from the previous quarter
AMRN's ROE has plunged by 81% YoY and by 11% from the previous quarter
The ROIC has shrunk by 53% YoY and by 4.2% QoQ
Dividends
What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AMRN.
Financial health
How did Amarin financials performed over time
AMRN's quick ratio is up by 26% year-on-year and by 3% since the previous quarter
AMRN's total liabilities is down by 25% year-on-year and by 9% since the previous quarter
AMRN's debt is 98% smaller than its equity
The equity has declined by 13% year-on-year and by 2.6% since the previous quarter
AMRN's debt is down by 5% year-on-year but it is up by 2.8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.